Sarepta Therapeutics (SRPT) Shares Outstanding (2010 - 2026)

Sarepta Therapeutics' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $106.2 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 8.11% year-over-year to $106.2 million in Q1 2026; TTM through Mar 2026 was $106.2 million, a 8.11% increase from a year earlier, with the FY2025 full-year figure at $105.6 million, up 8.99% from the prior year.
• Shares Outstanding (Entity) rose to $106.2 million in Q1 2026 per SRPT's latest filing, from $105.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $106.2 million in Q1 2026 and bottomed at $87253.0 in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $94.5 million (2024), against an average of $81.2 million.
• Across the five-year window, Shares Outstanding (Entity) plunged 99.89% in 2022 and surged 106647.2% in 2023, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $88.0 million in 2022, then increased by 6.57% to $93.7 million in 2023, then rose by 3.38% to $96.9 million in 2024, then grew by 8.99% to $105.6 million in 2025, then climbed by 0.58% to $106.2 million in 2026.
• Per Business Quant, the three latest SRPT Shares Outstanding (Entity) figures stand at $106.2 million (Q1 2026), $105.6 million (Q4 2025), and $105.4 million (Q3 2025).